Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nautilus Biotechnolgy, Inc. (NAUT)
:NAUT
RESEARCH TOOLSreports
Holding NAUT?
Track your performance easily
Earnings Data
Report Date
Feb 20, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.15Last Year’s EPS
-0.14Same Quarter Last Year
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 02, 2021
|% Change Since: -31.32%
|Next Earnings Date:Aug 10, 2021
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in proteoform data and cash management, yet challenges remain in achieving broadscale discovery milestones and probe candidate performance. Plans for commercial launch in late 2025 are still on track.Company Guidance
During Nautilus' Q3 2024 earnings call, the company provided guidance on its ongoing development in proteomic analysis and financial health. The company has made significant advances in targeting proteoform analysis, notably through collaborations like the one with Genentech, and aims to leverage this in the first half of 2025. While progress in broad-scale protein discovery was behind schedule, Nautilus remains confident in achieving the milestone of decoding 500-2,000 proteins from complex samples, which is essential for their broader commercial launch anticipated in late 2025. Financially, Nautilus reported total operating expenses of $19.1 million for Q3, consistent with the previous year, and a net loss of $16.4 million. The company ended the quarter with a robust cash position of $221.2 million, extending their cash runway into 2027, thanks to tight spending controls and a focus on prioritization.Core Platform Development Success
Nautilus demonstrated scalable and reliable processes for building flow cells and chips, consistent single molecule protein library preparation, and robust single molecule deposition.
Proteoform Data Presentation
Nautilus presented exciting new proteoform data at the World HUPO Congress, showcasing their platform's readiness and capabilities.
Partnership with Genentech
Developed a new assay for quantitative measurement of up to 2,048 proteoforms of the protein tau, which is important for Alzheimer's research.
Cash Management and Financial Health
Operating expenses for Q3 2024 were managed tightly, resulting in a cash balance of $221.2 million, extending cash runway into 2027.
Hiring of Ken Suzuki as Chief Marketing Officer
Ken Suzuki, with a 25-year career at Agilent Technologies, joins Nautilus to enhance marketing and strategy execution.
---
NAUT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NAUT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 29, 2024 | $2.81 | $2.77 | -1.42% |
| Jul 30, 2024 | $2.74 | $2.67 | -2.55% |
| Apr 30, 2024 | $2.57 | $2.54 | -1.17% |
| Feb 28, 2024 | $2.94 | $2.80 | -4.76% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Nautilus Biotechnolgy, Inc. (NAUT) report earnings?
Nautilus Biotechnolgy, Inc. (NAUT) is schdueled to report earning on Feb 20, 2025, TBA Not Confirmed.
What is Nautilus Biotechnolgy, Inc. (NAUT) earnings time?
Nautilus Biotechnolgy, Inc. (NAUT) earnings time is at Feb 20, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NAUT EPS forecast?
NAUT EPS forecast for the fiscal quarter 2024 (Q4) is -0.15.
---